Investor

Welcome to BioBT's Investor Corner

Dear Investors,
Thank you for your interest in BioBT®, a dynamic bootstrap startup dedicated to transforming the healthcare industry through cutting-edge technology. We are pleased to announce that, having achieved satisfactory results and successfully refined our core offerings, we are now open to exploring investment opportunities. We invite interest from both domestic and international investors, as well as major health companies and individual partners.

Our Vision: Advancing Healthcare Through Innovation

At BioBT®, our mission is to enhance patient care and diagnostic processes through innovative technology. With a robust machine line in place and extensive floor-level testing completed, we are well-positioned for growth and are now actively seeking strategic investments to support our next phase of development.

Pioneering AI Tools and Software Features

Our team remains at the forefront of healthcare technology, developing advanced AI tools and software features that are set to revolutionize the market. These innovations are designed to deliver instant and accurate diagnostic reports, expediting the healthcare process and improving patient outcomes.

Why BioBT?

  •  1:   Commitment to Quality: Our rigorous testing and development processes ensure our products meet the highest standards of quality and reliability.

  •  2:   Innovation at the Forefront: We pride ourselves on being pioneers, continuously introducing novel solutions to address critical healthcare challenges.

  •  3:   Patient-Centric Approach: We aim to empower patients and healthcare professionals with timely, precise diagnostic information, facilitating quicker and more informed decision-making.

As we embark on this exciting new phase, we are eager to engage with domestic and international investors, large health companies, and industrial partners who share our vision and values. Your support will be instrumental in helping us advance our mission and make a significant impact on the future of healthcare.

Thank you for your continued interest and support.

Sincerely,
BioBT Team